Karmanos Cancer Insitute

Detroit, Michigan 48201

1 studies enrolling now · 3 studies all time

What they study most

Head and Neck Cancer, Monoclonal Gammopathy, Non-Small Cell Lung Cancer, Smoldering Multiple Myeloma

Studies at this site

• Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients — Recruiting now
• Phase II Study of the CD38 Antibody Daratumumab in Patients With High-Risk MGUS and Low-Risk Smoldering Multiple Myeloma — Running, not enrolling
• SPEARHEAD 2 Study in Subjects With Recurrent or Metastatic Head and Neck Cancer — Withdrawn before enrolling